SCHEMBL15910220

SCHEMBL15910220

CC(C)(C)c1ccc2c(c1)c1cc(C(C)(C)C)ccc1n2-c1ccc2c(c1)c1cc(-n3c4ccc(C(C)(C)C)cc4c4cc(C(C)(C)C)ccc43)ccc1n2-c1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 2/20 0.43
▸ TP53 P04637 3/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ RAB9A P51151 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RXRA P19793 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ PPARG P37231 1/20 0.35
▸ GBA1 P04062 1/20 0.35
▸ PTGES O14684 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ RXRB P28702 1/20 0.35
▸ PGR P06401 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22065079 0.97 ABCG2 (0.45) ABCG2TP53SMN1; SMN2RAB9AMEN1
SCHEMBL17328024 0.96 ABCG2 (0.43) ABCG2TP53SMN1; SMN2RAB9AMEN1
SCHEMBL15910240 0.96 ABCG2 (0.43) ABCG2TP53SMN1; SMN2RAB9AMEN1
SCHEMBL15910165 0.96 ABCG2 (0.43) ABCG2TP53SMN1; SMN2RAB9AMEN1
SCHEMBL29365018 0.96 ABCG2 (0.44) ABCG2TP53SMN1; SMN2RAB9AMEN1
SCHEMBL28679875 0.96 ABCG2 (0.44) ABCG2TP53SMN1; SMN2RAB9AMEN1
SCHEMBL12033743 0.94 ABCG2 (0.41) ABCG2TP53SMN1; SMN2RAB9AMEN1
SCHEMBL12033588 0.93 ABCG2 (0.42) ABCG2TP53SMN1; SMN2RAB9AMEN1
SCHEMBL24414191 0.92 ABCG2 (0.42) ABCG2TP53SMN1; SMN2RAB9AMEN1
SCHEMBL32675502 0.92 ABCG2 (0.41) ABCG2TP53SMN1; SMN2RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2949724-B1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME KYULUX INC (JP) 2020-06-17 — — EP disclosed
US-20150357582-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING DEVICE USING SAME KYULUX, INC. (JP) 2015-12-10 — — US disclosed
EP-2949724-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME Kyushu University, National University Corporation (JP) 2015-12-02 — — EP disclosed
WO-2014115743-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME 国立大学法人九州大学 (JP) 2014-07-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150357582-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, INTS9 ABCG2 2798/4885TP53 4494/4885SMN1; SMN2 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback